Search research articles
Contact Us
Filters
Showing results (121-130 of 306) with videos related to
Page
of 31
Sort By:
The American Journal of Medicine
|
October 6, 2010
Diabetes enhances hepatocarcinogenesis in noncirrhotic, interferon-treated hepatitis C patients
Yusuke Kawamura, Yasuji Arase, Kenji Ikeda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
March 31, 2018
Recurrence rates of pruritus after the stop of nalfurafine hydrochloride in chronic liver disease: Preliminary prospective confirmatory trial
Norio Akuta, Hiromitsu Kumada, Shunichiro Fujiyama, et al.
Oncology
|
June 29, 2011
Previous chemoembolization response after transcatheter arterial chemoembolization (TACE) can predict the anti-tumor effect of subsequent TACE with miriplatin in patients with recurrent hepatocellular carcinoma
Norihiro Imai, Kenji Ikeda, Yuya Seko, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
October 23, 2021
Renal safety and biochemical changes for 2 years after switching to tenofovir alafenamide from long-term other nucleotide analog treatment in patients with chronic hepatitis B
Tetsuya Hosaka, Fumitaka Suzuki, Masahiro Kobayashi, et al.
Intervirology
|
January 8, 2009
Lipiodol and dye at the site of ablation decreases during RFA
Miharu Hirakawa, Kenji Ikeda, Yusuke Kawamura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
December 5, 2008
Efficacy of platinum analogue for advanced hepatocellular carcinoma unresponsive to transcatheter arterial chemoembolization with epirubicin
Yusuke Kawamura, Kenji Ikeda, Miharu Hirakawa, et al.
Journal of Medical Virology
|
June 14, 2018
Circulating microRNA-122 levels are important predictor of hepatitis B virus surface antigen seroclearance
Norio Akuta, Fumitaka Suzuki, Mariko Kobayashi, et al.
Journal of Hepatology
|
April 19, 2006
Prediction model of hepatocarcinogenesis for patients with hepatitis C virus-related cirrhosis. Validation with internal and external cohorts
Kenji Ikeda, Yasuji Arase, Satoshi Saitoh, et al.
Hepatology (Baltimore, Md.)
|
December 6, 2012
Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection
Tetsuya Hosaka, Fumitaka Suzuki, Masahiro Kobayashi, et al.
Journal of Medical Virology
|
October 25, 2013
Impact of virus clearance for the development of hemorrhagic stroke in chronic hepatitis C
Yasuji Arase, Mariko Kobayashi, Yusuke Kawamura, et al.
Page
of 31
Search research articles
Search
Showing results (121-130 of 306) with videos related to
Sort By:
Page
of 31
The American Journal of Medicine
|
October 6, 2010
Diabetes enhances hepatocarcinogenesis in noncirrhotic, interferon-treated hepatitis C patients
Yusuke Kawamura, Yasuji Arase, Kenji Ikeda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
March 31, 2018
Recurrence rates of pruritus after the stop of nalfurafine hydrochloride in chronic liver disease: Preliminary prospective confirmatory trial
Norio Akuta, Hiromitsu Kumada, Shunichiro Fujiyama, et al.
Oncology
|
June 29, 2011
Previous chemoembolization response after transcatheter arterial chemoembolization (TACE) can predict the anti-tumor effect of subsequent TACE with miriplatin in patients with recurrent hepatocellular carcinoma
Norihiro Imai, Kenji Ikeda, Yuya Seko, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
October 23, 2021
Renal safety and biochemical changes for 2 years after switching to tenofovir alafenamide from long-term other nucleotide analog treatment in patients with chronic hepatitis B
Tetsuya Hosaka, Fumitaka Suzuki, Masahiro Kobayashi, et al.
Intervirology
|
January 8, 2009
Lipiodol and dye at the site of ablation decreases during RFA
Miharu Hirakawa, Kenji Ikeda, Yusuke Kawamura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
December 5, 2008
Efficacy of platinum analogue for advanced hepatocellular carcinoma unresponsive to transcatheter arterial chemoembolization with epirubicin
Yusuke Kawamura, Kenji Ikeda, Miharu Hirakawa, et al.
Journal of Medical Virology
|
June 14, 2018
Circulating microRNA-122 levels are important predictor of hepatitis B virus surface antigen seroclearance
Norio Akuta, Fumitaka Suzuki, Mariko Kobayashi, et al.
Journal of Hepatology
|
April 19, 2006
Prediction model of hepatocarcinogenesis for patients with hepatitis C virus-related cirrhosis. Validation with internal and external cohorts
Kenji Ikeda, Yasuji Arase, Satoshi Saitoh, et al.
Hepatology (Baltimore, Md.)
|
December 6, 2012
Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection
Tetsuya Hosaka, Fumitaka Suzuki, Masahiro Kobayashi, et al.
Journal of Medical Virology
|
October 25, 2013
Impact of virus clearance for the development of hemorrhagic stroke in chronic hepatitis C
Yasuji Arase, Mariko Kobayashi, Yusuke Kawamura, et al.
Page
of 31